1. Home
  2. DBVT vs STG Comparison

DBVT vs STG Comparison

Compare DBVT & STG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • STG
  • Stock Information
  • Founded
  • DBVT 2002
  • STG 2003
  • Country
  • DBVT France
  • STG China
  • Employees
  • DBVT N/A
  • STG N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • STG Other Consumer Services
  • Sector
  • DBVT Health Care
  • STG Real Estate
  • Exchange
  • DBVT Nasdaq
  • STG Nasdaq
  • Market Cap
  • DBVT 102.0M
  • STG 91.6M
  • IPO Year
  • DBVT N/A
  • STG 2018
  • Fundamental
  • Price
  • DBVT $4.40
  • STG $6.16
  • Analyst Decision
  • DBVT Strong Buy
  • STG
  • Analyst Count
  • DBVT 2
  • STG 0
  • Target Price
  • DBVT $22.50
  • STG N/A
  • AVG Volume (30 Days)
  • DBVT 28.3K
  • STG 5.7K
  • Earning Date
  • DBVT 03-06-2025
  • STG 03-21-2025
  • Dividend Yield
  • DBVT N/A
  • STG N/A
  • EPS Growth
  • DBVT N/A
  • STG N/A
  • EPS
  • DBVT N/A
  • STG 4.57
  • Revenue
  • DBVT $12,515,000.00
  • STG $292,030,936.00
  • Revenue This Year
  • DBVT N/A
  • STG N/A
  • Revenue Next Year
  • DBVT $2,860.00
  • STG N/A
  • P/E Ratio
  • DBVT N/A
  • STG $1.35
  • Revenue Growth
  • DBVT 125.54
  • STG N/A
  • 52 Week Low
  • DBVT $0.44
  • STG $4.25
  • 52 Week High
  • DBVT $5.42
  • STG $12.55
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 54.39
  • STG 43.15
  • Support Level
  • DBVT $4.18
  • STG $6.46
  • Resistance Level
  • DBVT $4.47
  • STG $6.78
  • Average True Range (ATR)
  • DBVT 0.28
  • STG 0.15
  • MACD
  • DBVT -0.04
  • STG -0.06
  • Stochastic Oscillator
  • DBVT 71.34
  • STG 1.30

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

About STG Sunlands Technology Group

Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.

Share on Social Networks: